Nursing Research Committee
Study type:
Study number:
84150019
Type of treatment:
Allogeneic
Allogeneic - Related
Allogeneic - Unrelated
Allogeneic - Haploidentical
Autologous
CAR T
Diseases:
All diseases
Short title:
AIM-OrCa Study: Adoption and Implementation of Oral Care guidelines
Primary objective:
Which MASCC/ISOO and MASCC–EBMT oral care recommendations have been adopted by EBMT centers at the institutional level?
Key inclusion criteria:
EBMT centers performing autologous and/or allogeneic HCT, as well as those administering CAR T-cell therapies in adult and/or pediatric populations, will be eligible for inclusion. In addition, each participating center must have at least one identified contact person who is responsible for or knowledgeable about local oral care practices, such as a nursing lead, supportive care specialist, advanced practice nurse or transplant physician.
Country:
All EBMT member countries
Principal investigator:
Carlotta Cadsky
EBMT Study coordinator:
Brian Piepenbroek
Study coordinator email:
nursesgroup@ebmt.org
EBMT Study Unit:
Leiden Study Unit
Reason for processing personal data:
Not applicable to surveys
Categories of personal data collected:
Not applicable to surveys
Recipients who may access the data:
Not applicable to surveys
3rd-party processors of Personal Data on behalf of EBMT/Service provider:
Not applicable to surveys
Privacy notices
Article 6 lawful basis for processing personal data:
Not applicable to surveys
Article 9 basis for processing special category data:
Not applicable to surveys
Data Protection Impact Assessments
Rights available to individuals:
Access
Data portability
Rectification
Objection
Deletion
Is a Data Protection Impact Assessment required?:
Not applicable to surveys
Retention Schedule (if possible):
Not applicable to surveys